| |
Latest 10 SEC filings (by transaction date) for XBIT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 5/24 | Jan 3/24 | Simard John | Direct Ownership | Convertible Loan Agreement | P - Open market or private purchase | 2,470,355 | $10,000,000.00 |
Jun 26/23 | Jun 23/23 | Waldin Jan-Paul | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | Libby Peter | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | MacAdam Donald H. | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | Mckenzie W Thorpe | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for XBIT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 5/24 | Jan 3/24 | Simard John | Direct Ownership | Convertible Loan Agreement | P - Open market or private purchase | 2,470,355 | $10,000,000.00 |
Jun 26/23 | Jun 23/23 | Waldin Jan-Paul | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | Libby Peter | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | MacAdam Donald H. | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Jun 26/23 | Jun 23/23 | Mckenzie W Thorpe | Direct Ownership | Director Stock Option | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |